1. Name and nature of the target: DaChan (USA), Inc. common stock. 2. Date of occurrence: May 29, 2026. 3. Board approval date: May 29, 2026. 5. Transaction amount: Up to $40 million USD. 6. Counterparty: DaChan (USA), Inc. (100% owned subsidiary). 17. Purpose: Expansion into the US food processing market. 28. Funding source: Internal funds and bank loans.

FACT BOX

  • Source: PR Times
  • Category: Corporate Investment
  • Organizations: DaChan (USA), Inc.